Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

rapid-acting insulin aspart, and premix insulin preparations including the combination of insulin degludec and aspart. To improve the convenience of our medicines, we introduced the world’s ...

safety and ease of administration of the rapid-acting insulin analogue insulin aspart in comparison with human insulin (HI) in diabetes mellitus in the following categories: (a) in adults ...

Find all the commercial and brand names of generic drug called Insulin Aspart. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Biocon Ltd’s share price fell 4.86 per cent on January 27, 2025, hitting a day’s low of Rs 369.40 on the NSE, while the NIFTY ...

and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026. Fiasp's price will be reduced by 75%, making it the same price as NovoLog (insuin aspart), while Tresiba's price will be reduced ...

Ryzodeg (insulin degludec / insulin aspart) contains the new-generation once-daily basal insulin degludec in a soluble formulation with insulin aspart. Both of these products will be available in ...

Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

Rapid-acting insulin called insulin aspart - this lowers your blood sugar level soon after you inject it. Ryzodeg ® 70/30 is a modified insulin, also called an insulin analogue, which is similar ...